Drug Trial Radar · NCT03898479
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Last checked: Nov 19, 2026Latest source record: Oct 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Apr 4, 2019
Primary completion
May 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 2, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Conditions
- Alopecia Areata
Interventions
CTP-543Drug
Twice daily dosing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Adverse Events as a Measure of SafetyTime frame: 332 weeks
- Effect of CTP-543 on treating hair loss as measured by the Severity of Alopecia Tool (SALT)Time frame: 332 weeks
Locations
91 sites in 2 countries. Site status is shown where the registry gives one.
Total Skin and Beauty Dermatology Center
Birmingham, Alabama
Alliance Dermatology & MOHS Center
Phoenix, Arizona
Center for Dermatology and Plastic Surgery/CCT Research
Scottsdale, Arizona
Johnson Dermatology
Fort Smith, Arkansas
Northwest Arkansas Clinical Trials Center, PLLC
Rogers, Arkansas
Kern Research Inc.
Bakersfield, California
Hope Clinical Research
Canoga Park, California
California Dermatology & Clinical Research Institute
Encinitas, California
University of California, Irvine
Irvine, California
Dermatology Research Associates
Los Angeles, California
Quest Dermatology Research
Northridge, California
Kaiser Permanente Northern California - Oakland
Oakland, California
Palmtree Clinical Research, Inc.
Palm Springs, California
Stanford University School of Medicine - Medical Dermatology Clinic
Redwood City, California
Kaiser Permanente South Sacramento
Sacramento, California
Kaiser Permanente Clinical Trials Unit
San Francisco, California
Colorado Center for Dermatology, PLLC d/b/a CODerm Research
Centennial, Colorado
Colorado Medical Research Center
Denver, Colorado
Yale University Church Street Research Unit
New Haven, Connecticut
Skin Care Research, LLC
Boca Raton, Florida
Skin Care Research, LLC
Hollywood, Florida
University of Miami Hospital
Miami, Florida
Floridian Research Institute, LLC
Miami, Florida
Lenus Research & Medical Group, LLC
Sweetwater, Florida
Clinical Research Trials of Florida, Inc.
Tampa, Florida
ForCare Clinical Research
Tampa, Florida
ASR, LLC
Boise, Idaho
Denova Research
Chicago, Illinois
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
DS Research
New Albany, Indiana
The Indiana Clinical Trials Center, PC
Plainfield, Indiana
DS Research
Louisville, Kentucky
Qualmedica Research
Owensboro, Kentucky
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Clarkston Skin Research
Clarkston, Michigan
Clinical Research Institute of Michigan
Clinton Township, Michigan
Minnesota Clinical Study Center
Fridley, Minnesota
University of Minnesota Department of Dermatology
Minneapolis, Minnesota
Vivida Dermatology
Las Vegas, Nevada
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.